TB in India is a case in point that buying more healthcare doesn’t necessarily produce better health.
In 2020 Leapfrog to Value and USAID partnered to make the case for applying value-based care to addressing India’s TB epidemic.
USAID India Mission subsequently invested $8M in an ambitious 3 year program to test our core hypothesis: a human-centered approach to TB care can produce better outcomes at a better cost.
World Health Partners leads implementation of this program in four districts in Gujarat and Jharkhand.